Glenmark: Phase-3 trial of antiviral Favipavir shows significant faster time to clinical improvement

Glenmark Pharmaceuticals Ltd announced on Wednesday that the phase-3 clinical trial of Favipiravir in patients with mild-to-moderate COVID-19 demonstr
আরও পড়ুন Previous

South Africa Retail Sales (YoY) below forecasts (1.6%) in April: Actual (-12%)

South Africa Retail Sales (YoY) below forecasts (1.6%) in April: Actual (-12%)
আরও পড়ুন Next